|
FAM126A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.22124532708767E-15 |
| Normal-vs-Stage2 |
4.39790004413965E-09 |
| Normal-vs-Stage3 |
5.0108994731346E-10 |
| Normal-vs-Stage4 |
3.08553183003824E-12 |
| Stage1-vs-Stage2 |
3.595400E-01 |
| Stage1-vs-Stage3 |
8.697000E-01 |
| Stage1-vs-Stage4 |
7.143900E-02 |
| Stage2-vs-Stage3 |
4.676600E-01 |
| Stage2-vs-Stage4 |
6.866800E-01 |
| Stage3-vs-Stage4 |
2.030200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02085007114283E-12 |
| Normal-vs-AfricanAmerican |
1.84152693094575E-12 |
| Normal-vs-Asian |
7.296899995346E-08 |
| Caucasian-vs-AfricanAmerican |
1.573770E-02 |
| Caucasian-vs-Asian |
6.929200E-01 |
| AfricanAmerican-vs-Asian |
3.819700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.06909966727187E-10 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
1.404560E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.25930385511219E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
2.45109488261619E-11 |
| Normal-vs-Age(81-100Yrs) |
2.346600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.633910E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.218400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.464200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.258200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.734560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.340610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.417200E-01 |
| Classical-VS-Follicular |
5.68379999954516E-07 |
| Classical-VS-Other |
6.612000E-01 |
| Classical-VS-Normal |
4.55657733766657E-12 |
| Tall-VS-Follicular |
1.164240E-01 |
| Tall-VS-Other |
8.251800E-01 |
| Tall-VS-Normal |
1.048390E-04 |
| Follicular-VS-Other |
4.665400E-01 |
| Follicular-VS-Normal |
<1E-12 |
| Other-VS-Normal |
1.315140E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.20080000001843E-07 |
| N0-vs-N1 |
1.805000E-01 |
|
|
